- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04165382
Development, Implementation and Evaluation of a Clinical Practice Guideline for Care of Preterm Infants Receiving Non-invasive Ventilation (NIV)
A Before and After Study for Development, Implementation, and Evaluation of a Clinical Practice Guideline for Care of Preterm Infants Receiving Non-invasive Ventilation (NIV)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A workgroup is formed in the NICU to provide expert opinions in the process of development, implementation, and evaluation of the guideline. It consists of five nurses, one neonatologist and one physiotherapist. After that, 16 evidence-based articles were identified in several scientific databases, and practices in the guideline are developed after reviewed and appraised the articles.
Interventions in the guideline involve six components as
- choice of "right" nasal interfaces, in which the "right" size of nasal interface either short binasal prongs or nasal mask is chosen according to the size of the infant's nose and distance between two nasal nares. In addition, the "right" size of bonnet using to anchoring the ventilator tubing is also selected according to the size of infant's head.
- use of skin protective dressing, in which the hydrocolloid dressing is used to cover the skin areas underneath the nasal interface and anchoring straps;
- alternate the nasal interfaces from the short binasal prongs to nasal mask every 6 hours;
- positioning the infants regularly for 4-6 hours, at optimal developmental body position but avoid prone position, and well supporting the devices to prevent displacement and traction onto the infant's skin after changed position;
- supportive care including to wet the prongs with sterile water or saline before inserting into the nasal nares, to clean the infant's faces and nasal areas daily, to wipe away any water condensate over infant's nasal areas every 4-6 hours, to gently massage the areas during removal of the nasal interfaces or devices for examination at every routine care, to provide oral care every 3-4 hours and avoid unnecessary nasal suctioning, to provide adequate humidification to the ventilation circuit, to remove water condensate in the interfaces and ventilator circuit, to aspirate air from the gastric tube before every tube feeding to relieve abdominal distension;
- regular assessments on infants receiving NIV for pain level by Neonatal Pain, Agitation and Sedation Scale, intact of skin integrity for the areas in contacting with the nasal interfaces and devices of NIV, and to rate the severity of injury by the staging system from National Pressure Ulcer Advisory Panel.
The study includes two periods of "pre-implementation" and "post-implementation". In the pre-implementation period, all infants receiving NIV will be providing the usual care including choice of nasal interfaces in which larger or smaller interfaces may be given to the infant, use of skin protective dressing, positioning which is not restricted to the frequency of turning or types of position, supportive care of providing humidification to the ventilator circuit, oral care and avoiding of unnecessary nasal suctioning, removing of water condensate in the ventilator circuit, aspirating of air before alternate tube feeding.
A one-month training will be given to nurses working in the NICU after completion of the pre-implementation period. The training contains a dialect lecture, video demonstration of care, and scenario discussion.
After completion of the one-month training, the post-implementation period will be commenced, and the care in the guideline will be provided to infants receiving NIV.
Data collection on infant participants and nurses will be conducted during the study period.
Data analysis will be performed to evaluate the effectiveness of the guideline as well as the increase of nurses' knowledge in care of infants receiving NIV and their compliances to the guideline.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sin Yee CHAN
- Phone Number: +852-3506 7751
- Email: 1155101742@link.cuhk.edu.hk
Study Contact Backup
- Name: Janita Chau, Professor
- Phone Number: +852-39436226
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- Queen Elizabeth Hospital
-
Contact:
- Sin Yee Chan
- Phone Number: +852-35067751
- Email: bcsyz05@ha.org.hk
-
Principal Investigator:
- Sin Yee Chan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- the infant born before 37 completed weeks of gestation age
- receiving or started NIV via nasal prong or nasal mask at the supports as
- continuous positive airway pressure
- non-invasive intermittent positive pressure ventilation
- neural adjusted ventilatory assisted ventilation
Exclusion Criteria:
- infants with the chromosomal abnormalities (e.g. Pierre Robin Sequence)
- complex heart problems (e.g. transposition of great arteries, Tetralogy of Fallot, Coarctation of Aorta)
- severe respiratory disorders/diseases (e.g. diaphragmatic hernia, tracheoesophageal fistula, cystic fibrosis, congenital cystic adenomatoid malformation)
- craniofacial anomalies (e.g. bilateral cleft lip,cleft palate, choanal atresia)
- congenital skin disorders (e.g. collodion baby)
- severe acute conditions (e.g. necrotizing enterocolitis, pneumothorax, intraventricular haemorrhage, severe sepsis)
- parents or legal guardian refuse to join the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Pre-implementation study group
Preterm infants receiving NIV before the implementation of the guideline
|
Usual care includes the choice of nasal interface for NIV; use of skin protective dressing; positioning of infants without specific frequency or types of position; supportive care as to provide humidification to the ventilator circuit, to remove water condensate in the ventilator circuit, to provide oral care every 3-4 hours and avoid unnecessary nasal suctioning.
Other Names:
|
Other: Post-implementation study group
Preterm infants receiving NIV after the implementation of the guideline
|
Interventions in the guideline involve six components as
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
nasal injury
Time Frame: receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
infant's severity of nasal injury rated by the staging system from National Pressure Ulcer Advisory Panel
|
receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
pain level
Time Frame: receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
infant's pain level rated by the Neonatal Pain, Agitation and Sedation Scale (N-PASS) with minimum score at 0 and maximum score at 11 for preterm < 30 weeks & 10 for infants > or = 30 weeks.
To study whether the interventions of the guideline can promote comfort for preterm infants receiving NIV, by studying indirectly on the pain level.
For each infant participant, baseline of pain level will be obtained at the beginning of NIV, then pain score will be assessed every shift or every routine care (at least 4 hours) if the baseline score >3.
If the pain score reduce or remain unchanged after implementation of the guideline, it shows the comfort of the infants receiving NIV
|
receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
activity level
Time Frame: receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
infant's activity level including sleep, active, quiet, irritable and unresponsive evaluated in hourly nursing assessment
|
receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
body weight
Time Frame: receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
infant's body weight weighed by the baby weight scale every alternate day
|
receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
abdominal girth
Time Frame: receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
infant's abdominal girth by the measuring tape every morning before feeding
|
receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
knowledge level of caring infants receiving NIV
Time Frame: once before the training, once just after the training, once at 12-week after completion of the one-month training in the NICU
|
self-developed questions as "pre-test" and "post-test" to assess nurses' knowledge of caring infants receiving NIV, the minimum score of the test is 0 and maximum is 10, the differences between the score obtained in "pre-test" and "post-test" indicates any increase of knowledge level of caring infants receiving NIV
|
once before the training, once just after the training, once at 12-week after completion of the one-month training in the NICU
|
Compliance to the guideline
Time Frame: once as baseline record in the pre-implementation period, once at 12-week and once at 24-week since the commencement of post-implementation period
|
self-developed audit tool to assess nurses' compliance to the guideline
|
once as baseline record in the pre-implementation period, once at 12-week and once at 24-week since the commencement of post-implementation period
|
ventilation day
Time Frame: receiving ventilation support through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
total ventilation days for infant receiving NIV and receiving invasive ventilation before changed to NIV
|
receiving ventilation support through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
Efficacy of NIV
Time Frame: receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
study the total ventilation day for infants receiving NIV, and any failure of NIV as indicated by infant requiring intubation for the invasive ventilation within 24-hour after receiving NIV
|
receiving NIV through study period completion, an average of 6 months for pre-implementation group, and 8 months for post-implementation group
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sin Yee Chan, The Queen Elizabeth Hospital
- Study Chair: Janita Chau, Professor, Chinese University of Hong Kong
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KC/KE-19-0093/ER-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Noninvasive Ventilation
-
University of AlbertaWithdrawn
-
Chongqing Medical UniversityCompleted
-
Hospital San Carlos, MadridHospital Universitario Ramon y Cajal; Hospital Universitario Virgen de la Arrixaca and other collaboratorsRecruitingNoninvasive Ventilation | Trophic NutritionSpain
-
University of UtahNational Heart, Lung, and Blood Institute (NHLBI); National Institute of Nursing... and other collaboratorsCompletedNoninvasive Ventilation | Speech IntelligibilityUnited States
-
University of AlbertaStollery Children's HospitalRecruitingChild, Only | Adherence, Patient | Noninvasive VentilationCanada
-
University Hospital, MontpellierAssociation pour l'Assistance et la Réhabilitation à Domicile (APARD)CompletedNoninvasive Ventilation | Continuous Positive Airway PressureFrance
-
Prince of Songkla UniversityCompletedNewborn Morbidity | Noninvasive Ventilation | High-Frequency Ventilation | Intermittent Positive-Pressure VentilationThailand
-
Guilherme Sant'Anna, MDUnknown
-
University of Missouri-ColumbiaCompletedEffect of Head Rotation on Efficacy of Face Mask Ventilation in Anesthetized Obese (BMI ≥ 35) AdultsNoninvasive VentilationUnited States
-
University Hospital Inselspital, BerneCompletedNoninvasive Ventilation | Hemodynamics | Heart Function Tests | Circulatory and Respiratory Physiological PhenomenaSwitzerland
Clinical Trials on Usual care to infants receiving NIV
-
Karolinska InstitutetThe Swedish Research CouncilCompletedCerebral Palsy | Gross Motor Development DelaySweden
-
Rigshospitalet, DenmarkUniversity College CopenhagenNot yet recruitingPost-Concussion Syndrome
-
University of MinnesotaNational Institute on Aging (NIA)CompletedDementia | Alzheimer Disease | Memory LossUnited States
-
Ross HaysCompletedReducing Post Traumatic StressUnited States
-
University of PittsburghCompletedDiabetes MellitusUnited States
-
Servicio Canario de SaludInstituto de Salud Carlos III; Asociación para la Diabetes de Tenerife; Asociación...CompletedType 2 Diabetes MellitusSpain
-
Universiteit AntwerpenUniversity Hospital, Antwerp; Research Foundation FlandersCompleted
-
KU LeuvenCompleted
-
University of PennsylvaniaAbramson Cancer Center of the University of PennsylvaniaCompleted
-
University of Medicine and Pharmacy at Ho Chi Minh...University of California, Davis; National Geriatric HospitalRecruiting